[Our experience with a clinical trial of the antibiotic thienam in puerperae and gynecologic patients with inflammatory diseases].
Pranchev
N
N
Katranushkova
N
N
Karadzhova
R
R
Doganov
N
N
Nalbanski
B
B
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D015377:Cilastatin / Q000009:adverse effects / Q000627:therapeutic use; D000077728:Cilastatin, Imipenem Drug Combination; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004338:Drug Combinations / Q000009:adverse effects / Q000627:therapeutic use; D004361:Drug Tolerance; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D015378:Imipenem / Q000009:adverse effects / Q000627:therapeutic use; D011247:Pregnancy; D011645:Puerperal Infection / Q000188:drug therapy* / Q000382:microbiology
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D015377:Cilastatin; D015378:Imipenem; D000077728:Cilastatin, Imipenem Drug Combination
Nashiiat opit ot klinichnoto izpitvane na antibiotika tienam pri rodilki i ginekologichno bolni s vŭzpalitelni zaboliavaniia.